AAV-DJ was engineered via DNA family shuffling technology which created a hybrid capsid from 8 AAV serotypes. This resulting vector mediates superior in vitro transduction efficiencies in comparison with any other wild type serotypes and higher infectivity rates across a broad range of cells and tissue types. AAV-DJ/8 is a mutant of AAV-DJ that exhibits increased uptake in brain tissue in vivo, similar to AAV-8 and AAV-9. For more information, click here.
Categories